Takeda Pharmaceutical Company Limited
Heterocyclic compound

Abstract:

The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).